08247 BIOSINO BIO-TEC
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 0.97X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 4.1% | Net Margin | N/A |
Total Debt/Equity | 91.7% | Return on Equity | N/A |
Price/Book | 0.49X | Return on Assets | N/A |
(HKD 0.610) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -45.23 | -12.84 | 9.09 | -1.39 | 3.23 |
---|---|---|---|---|---|
Net Profit Growth (%) | -252.3 | -241.3 | +751.8 | -143.2 | +102.6 |
Earnings Per Share (HKD) | -0.313 | -0.089 | 0.063 | -0.01 | 0.022 |
Earnings Per Share Growth (%) | -252.4 | -241.2 | +754.2 | -143.1 | +102.6 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | 9.71 | N/A | 27.35 |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 1.233 | 1.603 | 1.595 | 1.489 | 1.454 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 263.069 | 289.073 | -9.0 | 373.071 |
Operating Result | -59.304 | -29.959 | +98.0 | 11.982 |
Associates | -0.416 | 12.346 | -103.4 | 6.534 |
Profit Before Taxation | -59.72 | -17.613 | +239.1 | 18.516 |
Taxation | -2.831 | 1.628 | -273.9 | 4.314 |
Profit /( Loss) After Taxation | -56.889 | -19.241 | +195.7 | 14.202 |
Minority Interests | -14.357 | -7.593 | +89.1 | 6.096 |
Net Profit | -42.532 | -11.648 | +265.1 | 8.106 |
Earnings Per Share () | -0.3126 | -0.0887 | +252.4 | 0.0628 |
Announcement Date | 2025-03-31 | 2024-03-28 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25